Algorithmic pricing is being used in Canada. Why many want it banned – National
Most Canadians want the government to ban or regulate algorithmic pricing, a new poll suggests — with half…
Is $1 million enough to retire? What really matters
The 5 big risks that shape retirement “You can’t assume anything based on account size alone. Instead of…
Young CEOs under 35 making waves in Indian business
Q1 of 2026 acts as a signal to show that the ‘Young Leaders’ (featured in the image above)…
Think the RAM Crisis Is Bad Now? It Just Keeps Getting Worse
Unless the AI bubble bursts and sends all those planned data center projects packing, you won’t see an…
As PST expansion looms, B.C. businesses lose confidence
Businesses in B.C are losing confidence about the future of their operations due to rising energy prices and…
Pension Amount Becomes Attachable After Being Credited To Account; Recovery As Guarantor Valid: J&K&L High Court
The Jammu & Kashmir and Ladakh High Court has held that the protection available to pension amounts from…
Ambition, access and alignment: What’s driving India’s VC leadership churn
“This is not a disruption—it’s a sign that the ecosystem is evolving.” That is how Deepak Gupta, General…
Here’s where Canadians are travelling during March break amid global conflicts – CTV News
Here’s where Canadians are travelling during March break amid global conflicts CTV NewsEurope’s biggest airlines say fuel price spike…
Goldman Sachs flags upside risks to oil prices in near term and into 2027
Goldman Sachs said on Thursday that risks to oil prices remain skewed to the upside both in the…
April 2026 payments dates for universal credit, PIP, benefits and pensions plus cost of living support
Your support helps us to tell the story From reproductive rights to climate change to Big Tech, The…
Growing too fast nearly sank company—how we fixed it
This story is part of CNBC Make It’s The Moment series, where highly successful people reveal the critical moment that…
FDA approves high-dose Wegovy shots
Federal regulators on Thursday approved a new higher-dose version of the blockbuster obesity drug Wegovy that may help…